The recognition pathway: reconceiving inventorship and obviousness for iterative CRISPR-AI convergence
Journal of Law and the Biosciences · 07.07.2026 · 13 (2)
DOI: 10.1093/jlb/lsag028 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Law and the Biosciences, online erschienen am 10.11.2026. Verfasst von Hassan Abdulhakim Bahebe und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Law, Xi'an Jiaotong University, Xi'an, Shaanxi, China. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Clustered Regularly Interspaced Short Palindromic Repeats -Artificial Intelligence (CRISPR-AI) convergence generate therapeutic candidates via iterative human-machine workflows that disrupt the inventorship criterion of patent law based on conception. In CRISPR-AI studies, AI systems suggest thousands of guide RNAs or Cas variants; human researchers select, confirm, and optimize them via experimental feedback loops that conceal the locus of conception. The existing patent doctrine, which demands a clear and final concept in the human mind, fails to align with inventions in which AI comes up with solutions that human researchers had not anticipated. This Article advances a recognition pathway for CRISPR-AI inventorship that maintains the natural-person baseline while attributing inventorship to humans who exercise claim-defining technical judgment in identifying patentable value within AI outputs. The Article reconceives the person having ordinary skill in the art standard for AI-enhanced biotechnology, rejecting both inflexible pre-AI baselines and the 'computer having ordinary skill in the art' proposal. A five-factor test is employed to assess AI-generated CRISPR inventions on non-obviousness in terms of problem structure, predictability of solutions, and quality of human judgment. The framework provides a computational biotechnology human-accountability grammar that is administrable, but not legally granted to machines.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Law, Xi'an Jiaotong University, Xi'an, Shaanxi, China.
Zitieren
APA
Bahebe, H. A., & Xiaoming, L. (2026). The recognition pathway: reconceiving inventorship and obviousness for iterative CRISPR-AI convergence. Journal of Law and the Biosciences, 13(2). https://doi.org/10.1093/jlb/lsag028
Vancouver
Bahebe HA, Xiaoming L. The recognition pathway: reconceiving inventorship and obviousness for iterative CRISPR-AI convergence. Journal of Law and the Biosciences. 2026;13(2). doi:10.1093/jlb/lsag028
BibTeX
@article{Bahebe2026,
author = {Bahebe, Hassan Abdulhakim and Xiaoming, Li},
title = {The recognition pathway: reconceiving inventorship and obviousness for iterative CRISPR-AI convergence},
journal = {Journal of Law and the Biosciences},
year = {2026},
volume = {13},
number = {2},
doi = {10.1093/jlb/lsag028}
}
EUVIMED